Optic Glioma: Clinical Trials

4 trials for Optic Glioma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 recruiting, 1 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 1, Terminated 1

Follow Optic Glioma: new trials by email Literature Review of Optic Glioma trials Research Report on Optic Glioma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Modified CV Regimen in Optic Pathway Glioma
Carboplatin, Vincristine, Recombinant human endostatin - Optic Glioma, Pediatric Brain Tumor, Optic Nerve Glioma
Phase 2RecruitingBeijing Sanbo Brain Hospital752022-04-132024-10-15
Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
MRI-guided laser ablation, Doxorubicin, Etoposide - Glioma, Pilocytic Astrocytoma
Phase 2TerminatedWashington University School of Medicine62015-08-142024-11-01
PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1)
Neurofibromatosis-1, Optic Glioma
CompletedUNC Lineberger Comprehensive Cancer Center302013-01-162021-05-12
Natural History Study of Patients With Neurofibromatosis Type I
Neurofibromatosis Type 1, Malignant Peripheral Nerve Sheath Tumor
Active not recruitingNational Cancer Institute (NCI)2592008-02-252026-11-12

Narrower conditions

Optic Nerve Glioma (4)  ·  Neurofibroma, Plexiform (2)  ·  Astrocytoma (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Neurofibroma (1)  ·  Neurofibromatosis 1 (1)  ·  Neurofibrosarcoma (1)  ·  Oligodendroglioma (1)

Broader conditions

Cranial Nerve Diseases (4)  ·  Cranial Nerve Neoplasms (4)  ·  Eye Diseases (4)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms by Site (4)  ·  Neoplasms, Germ Cell and Embryonal (4)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Neoplasms, Nerve Tissue (4)  ·  Neoplasms, Neuroepithelial (4)  ·  Nervous System Diseases (4)  ·  Nervous System Neoplasms (4)  ·  Neuroectodermal Tumors (4)  ·  Optic Nerve Diseases (4)  ·  Optic Nerve Neoplasms (4)

Interventions

Carboplatin (1)  ·  Doxorubicin (1)  ·  Dynamic Contrast Enhanced Magnetic Resonance Imaging (1)  ·  Endostatins (1)  ·  Etoposide (1)  ·  Perfusion Magnetic Resonance Imaging (1)  ·  Vincristine (1)  ·  etoposide phosphate (1)

Sponsors

Beijing Sanbo Brain Hospital (1)  ·  National Cancer Institute (NCI) (1)  ·  UNC Lineberger Comprehensive Cancer Center (1)  ·  Washington University School of Medicine (1)

Countries

United States (3)  ·  China (1)

Top investigators

Andrew Cluster, M.D. (1)  ·  Brigitte C Widemann, M.D. (1)  ·  Timothy Gershon, MD, PhD (1)

Results publications

PMID 24321536, PMID 32152628, PMID 35007270, PMID 39418437